Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)

Japan flag Japan · Delayed Price · Currency is JPY
74.00
+1.00 (1.37%)
Jul 16, 2026, 9:24 AM JST
Market Cap10.86B +313.3%
Revenue (ttm)18.78M -36.1%
Net Income-729.80M
EPS-9.16
Shares Out 148.79M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume934,400
Open73.00
Previous Close73.00
Day's Range72.00 - 76.00
52-Week Range41.00 - 350.00
Beta1.79
Analystsn/a
Price Targetn/a
Earnings DateAug 10, 2026

About TYO:4596

Kubota Pharmaceutical Holdings Co., Ltd. engages in the pharmaceutical and medical device business worldwide. The company offers eyeMO, a remote retinal monitoring device for home-based and patient self-monitoring optical coherence tomography; and a NASA high-res version OCT device. It also provides Emixustat HCI compounds for Stargardt disease indications in Phase 3 clinical trials, as well as proliferative diabetic retinopathy and diabetic macular edema in Phase 2 clinical trials. The company was founded in 2002 and is headquartered in Minato... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 8
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4596
Full Company Profile

Financial Performance

In 2025, TYO:4596's revenue was 21.00 million, a decrease of -22.22% compared to the previous year's 27.00 million. Losses were -676.00 million, -49.25% less than in 2024.

Financial Statements